Global Postoperative Pain Therapeutics Market Share, Growth, Outlook 2024-2032
IMARC Group, a leading market research company, has recently releases report titled “Postoperative Pain Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global postoperative pain therapeutics market share, size, growth, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Postoperative Pain Therapeutics
Postoperative pain therapeutics encompass a range of medical interventions aimed at relieving pain experienced by patients after surgical procedures. They comprise opioids and non-steroidal anti-inflammatory drugs (NSAIDs), which reduce inflammation and provide pain relief without the sedative effects of opioids. They also include local anesthetics, which can be administered through nerve blocks, epidurals, or wound infiltration to numb specific areas, reducing pain. They often employ multimodal approaches, combining various techniques and medications to address pain from different angles. They involve understanding the pain threshold of the patient, addressing pre-existing conditions, and considering the type of surgery performed. They facilitate effective postoperative pain management, which is essential for patient comfort and satisfaction, promoting a more positive surgical experience. They are also crucial for allowing patients to engage in early mobilization and rehabilitation. They help to mitigate the risks of pneumonia, blood clots, and wound infections caused by untreated or poorly managed postoperative pain.
How Big Is the Postoperative Pain Therapeutics Market?
The global postoperative pain therapeutics market size reached US$ 13.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.86% during 2024-2032.
Request Sample Copy of This Report: https://www.imarcgroup.com/postoperative-pain-therapeutics-market/requestsample
What are the growth prospects and trends in the postoperative pain therapeutics industry?
At present, the rising awareness among healthcare professionals and patients about the importance of pain management in the postoperative period is promoting the adoption of innovative therapeutics. Besides this, the increasing development of novel drugs and therapies that offer improved pain relief while minimizing side effects is contributing to the growth of the market. In addition, the integration of digital health solutions and wearable devices in postoperative pain management is becoming a driving force, offering real-time data monitoring, patient engagement, and personalized treatment options.
These tools empower patients to actively participate in their pain management while also enabling healthcare providers to remotely assess and adjust treatment plans. Additionally, the shift towards value-based healthcare models is spurring the formation of outcome-based payment systems, emphasizing the need for effective postoperative pain therapeutics to ensure patient satisfaction and successful recovery.
Furthermore, the growing occurrence of arthritis and osteoporosis among the masses, causing knee and joint pain, is offering a favorable market outlook.
What is included in market segmentation?
The report has segmented the market into the following categories:
Drug Class Insights:
- Opioids
- NSAIDs
- Local Anesthetics
- Tricyclic Antidepressants
- Antiepileptic Drugs
- Others
Route of Administration Insights:
- Oral
- Intravenous
- Intramuscular
- Others
Distribution Channel Insights:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
Heron Therapeutics, Mallinckrodt Pharmaceuticals, Pacira BioSciences, Inc., Pfizer, Inc., Trevena, Inc.
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
